Last Update 26 Jun 26
Fair value Decreased 14%SOLB: Rare Earth Capabilities And Patent Ruling Will Support Upside Potential
Analysts now set Solvay’s fair value at €32, down from €37. This reflects a more cautious view on revenue growth and profit margins, even as some expect the company’s rare earth capabilities to support shareholder value over time.
Analyst Commentary
Recent research on Solvay shows a mix of caution and optimism, with some bullish analysts pointing to specific levers that could support the stock over time. For readers, the key is to separate where sentiment is becoming more constructive from where expectations are simply being reset.
On the more cautious side, the new fair value estimates and price targets suggest that analysts are reassessing Solvay’s revenue and margin outlook. At the same time, there is a clear thread of confidence around the company’s rare earth capabilities and the potential for these assets to support shareholder value.
Price targets now cluster around the mid to high €20s and low €30s. This frames a tighter debate about what investors are willing to pay for Solvay, given execution risks and the opportunities tied to its portfolio.
Bullish Takeaways
- Bullish analysts see Solvay’s rare earth capabilities as a key asset that could support shareholder value creation over time, which feeds directly into their valuation work.
- The upgrade to a more neutral stance from a previously more negative view signals that some bearish arguments have softened. This can help reduce downside sentiment around the stock.
- The price target of €30 from JPMorgan, alongside other targets in the mid to high €20s, indicates that some analysts still see valuation support for Solvay’s equity, even with more cautious growth and margin assumptions.
- Positive commentary around the company’s portfolio and capabilities gives Solvay some scope, in bullish analysts’ views, to improve execution and potentially justify fair values closer to the upper end of current target ranges.
What’s in the News for Solvay
- The European Patent Office (EPO) has upheld Solvay’s European patent EP 3 971 138 B1, which covers a proprietary process for treating and recycling purge streams in sodium carbonate and sodium bicarbonate production.
- The ruling follows opposition proceedings initiated by competitor WE Soda Ltd., with the patent maintained subject to limited amendments. This supports Solvay’s legal position in this dispute. (Source: European Patent Office case summary)
- Solvay has stated it intends to continue protecting its patents and to pursue legal actions against infringements worldwide. This signals an ongoing focus on patent enforcement across its portfolio. (Source: Company statements reported in recent coverage)
Valuation Changes for Solvay
- Fair Value: revised down from €37.0 to €32.0, indicating a moderate reduction in what analysts currently see as a central value marker for Solvay’s equity.
- Discount Rate: adjusted slightly lower from 8.19% to 7.98%, which marginally reduces the required return used in analysts’ valuation models.
- Revenue Growth: the assumed decline has widened from roughly 0.62% to 1.54%, reflecting a more cautious stance on Solvay’s top line trajectory.
- Profit Margin: the projected net profit margin has been trimmed from about 10.63% to 10.15%, pointing to slightly tighter expectations for Solvay’s earnings efficiency on each € of revenue.
- Future P/E: the forward valuation multiple has eased from 9.56x to 9.30x, implying a marginally lower earnings multiple in analysts’ updated models.
Catalysts
About Solvay
Solvay is a global leader in essential chemistry, leveraging industrial scale, digitalization and energy transition to supply key materials for advanced and resilient value chains.
What are the underlying business or industry changes driving this perspective?
- Scaling a digital first, AI ready industrial model through condition based monitoring and standardized real time dashboards should structurally lower fixed and variable costs, supporting higher EBITDA margins and more resilient earnings across cycles.
- Execution of the EUR 350 million operational excellence and spending review program by 2028, with EUR 200 million already targeted by 2025, is set to permanently reset the cost base, widening net margins even if volumes remain subdued.
- Expansion in electronic grade hydrogen peroxide and silica aligned with rising semiconductor and data center demand is positioning Solvay to capture higher value volumes, lifting revenue mix quality and long term EBITDA growth.
- Rapid build out of rare earth separation and purification capacity in Europe, including light and heavy elements for permanent magnets, targets structurally growing demand from electrification and energy transition, supporting multi year revenue growth and higher returns on invested capital.
- Energy transition projects and coal phaseout, combined with strategic optimization of CO2 emission rights, should reduce cash energy costs and carbon exposure, underpinning free cash flow generation and de risking long term earnings.
Assumptions
How have these above catalysts been quantified?
- This narrative explores a more optimistic perspective on Solvay compared to the consensus, based on a Fair Value that aligns with the bullish cohort of analysts.
- The bullish analysts are assuming Solvay's revenue will decrease by 1.5% annually over the next 3 years.
- The bullish analysts assume that profit margins will increase from -0.5% today to 10.2% in 3 years time.
- The bullish analysts expect earnings to reach €450.3 million (and earnings per share of €3.36) by about June 2029, up from -€25.0 million today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as €211.3 million.
- In order for the above numbers to justify the price target of the more bullish analyst cohort, the company would need to trade at a PE ratio of 9.4x on those 2029 earnings, up from -112.9x today. This future PE is lower than the current PE for the GB Chemicals industry at 13.1x.
- The bullish analysts expect the number of shares outstanding to grow by 0.09% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 7.98%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?
- Prolonged global overcapacity in soda ash and structurally weak seaborne demand in Southeast Asia could keep prices at or near cash cost for years, forcing further curtailments at European plants and depressing group revenue and EBITDA from the Basic Chemicals segment.
- Tariff and trade headwinds facing the Coatis business, including elevated U.S. import tariffs on Brazilian products and intense competition from Asian players, may represent a longer term shift rather than a cyclical dip, leading to persistently lower volumes, weaker pricing power and structurally compressed segment margins and earnings.
- The heavy reliance on cost savings, CO2 emission rights optimization and digital efficiency gains to sustain profitability in a flat to declining volume environment risks masking underlying demand weakness, so if savings taper off or carbon monetization becomes less attractive, group EBITDA margins and net income could fall back toward pre program levels.
- Strategic capacity reductions and site consolidations in Europe, undertaken to protect competitiveness and complete the energy transition, could limit Solvay's ability to participate in any eventual volume recovery in key markets such as soda ash and Performance Chemicals, capping long term revenue growth and operating leverage on earnings.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The assumed bullish price target for Solvay is €32.0, which represents up to two standard deviations above the consensus price target of €25.1. This valuation is based on what can be assumed as the expectations of Solvay's future earnings growth, profit margins and other risk factors from analysts on the bullish end of the spectrum.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €32.0, and the most bearish reporting a price target of just €18.0.
- In order for you to agree with the more bullish analyst cohort, you'd need to believe that by 2029, revenues will be €4.4 billion, earnings will come to €450.3 million, and it would be trading on a PE ratio of 9.4x, assuming you use a discount rate of 8.0%.
- Given the current share price of €26.98, the analyst price target of €32.0 is 15.7% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Solvay?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystHighTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystHighTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystHighTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
